ALECENSA , brand name of alectinib by Roche is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and whose type of NSCLC is caused by an abnormal anaplastic lymphoma kinase (ALK) gene.
